References
- Drossman DA. Irritable bowel syndrome: a multifactorial disorder. Hosp Pract (Off Ed) 1988; 23(9): 119–33
- Reeves-Darby V, Mathias JR. Motility disorders of the small intestine. Contemp Intern Med 1991; 3(10): 92–113
- Mathias JR, Ferguson KL, Clench MH. Debilitating “functional” bowel disease controlled by leuprolide acetate, gonadotropin-releasing hormone (GnRH) analog. Dig Dis Sci 1989; 34(5): 761–6
- Heitkemper MM, Jarrett M. Pattern of gastrointestinal and somatic symptoms across the menstrual cycle. Gastroenterology 1992; 102(2): 505–13
- Turnbull GK, Thompson DG, Day S, et al. Relationships between symptoms, menstrual cycle and orocaecal transit in normal and constipated women. Gut 1989; 30(1): 30–4
- Yen SS, Lein A. Mammals: man. In: Lamming GE, ed. Marshall's physiology of reproduction. 4th ed, vol 1. New York: Churchill Livingstone, 1984: 713–88
- Clinical applications of gonadotropin-releasing hormone and gonadotropin-releasing hormone analogs. Fertil Steril 1983; 39(3): 257–66
- Wald A, Van Thiel DH, Hoechstetter L, et al. Gastrointestinal transit: the effect of the menstrual cycle. Gastroenterology 1981; 80(6): 1497–500
- Nishikori K, Weisbrodt NW, Sherwood OD, et al. Relaxin alters rat uterine myosin light chain phosphorylation and related enzymatic activities. Endocrinology 1982; 111(5): 1743–5
- Davis RH, Clench MH, Mathias JR, et al. Effects of domperidone in patients with chronic unexplained upper gastrointestinal symptoms: a double-blind, placebo-controlled study. Dig Dis Sci 1988; 33(12): 1505–11
- Mathias JR, Sninsky CA, Millar HD, et al. Development of an improved multi-pressure-sensor probe for recording muscle contraction in human intestine. Dig Dis Sci 1985: 30(2): 119–23
- Mathias JR, Clench MH, Davis RH, et al. Migrating action potential complex: unmasked by 6-hvdroxvdopamine. Am J Physiol 1985; 249(3 Pt 1): G416–21
- Mathias JR, Finelli DS. Functional diseases of the small intestine. In: Cohen S, Soloway RD, eds. Functional disorders of the gastrointestinal tract. New York: Churchill Livingstone, 1987: 39–58
- Schuffler MD. Chronic intestinal pseudoobstruction syndromes. Med Clin North Am 1981: 65(6): 1331–58
- Smout AJ, De Wilde K, Kooyman CD, et al. Chronic idiopathic intestinal pseudo-obstruction: coexistence of smooth muscle and neuronal abnormalities. Dig Dis Sci 1985: 30(3): 282–7
- Camilleri M, Malagelada JR, Abell TL, et al. Effect of six weeks of treatment with cisapride in gastroparesis and intestinal pseudoobstruction. Gastroenterology 1989; 96(3): 704–12
- Janssens J, Peeters TL, Vantrappen G, et al. Improvement of gastric emptying in diabetic gastroparesis by erythromycin: preliminary, studies. N Engl J Med 1990: 322(15): 1028–31
- Soudah HC, Hasler WL, Owyang C. Effect of octreotide on intestinal motility and bacterial overgrowth in scleroderma. N Engl J Med 1991; 325(21): 1461–7
- Khanna R, Browne RM, Heiner AD, et al. Leuprolide acetate affects intestinal motility in female rats before and after ovariectomy. Am J Physiol 1992; 262(1 Pt l): G185–90
- Mathias JR, Baskin GS, Reeves-Darby VG, et al. Chronic intestinal pseudoobstruction in a patient with heart-lung transplant: therapeutic effect of leuprolide acetate. Dig Dis Sci 1992; 37(11): 1761–8
- Mathias JR, Clench MH, Reeves-Darby VG, et al. Effect of leuprolide acetate in patients with moderate to severe functional bowel disease: a double-blind, placebo-controlled study Dig Dis Sci 1994: 39(6): 1155–62
- Mathias JR, Clench MH, Roberts PH, et al. Effect of leuprolide acetate in patients with functional bowel disease: long-term follow-up after double-blind, placebo-controlled study. Dig Dis Sci 1994: 39(6): 1163–70